Showing results (1381-1390 of 1,587) with videos related to

Sort By:
Pageof 159
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 8, 2013
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research ConsortiumJonathan S Berg, Laura M Amendola, Christine Eng, et al.
Elife|October 4, 2018
Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics studyChristi T Salisbury-Ruf, Clinton C Bertram, Aurelia Vergeade, et al.
Plos One|February 23, 2012
Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcomeDavid A Engler, Sumeet Gupta, Whitfield B Growdon, et al.
BMC Medical Genomics|February 21, 2009
High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarraysYuker Wang, Victoria E H Carlton, George Karlin-Neumann, et al.
Nature Medicine|April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyEric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
NPJ Precision Oncology|March 27, 2021
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analyticsAllen Li, Jamie M Keck, Swapnil Parmar, et al.
Cancer Research|September 17, 2005
Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinomaAngela Bik-Yu Hui, Yvonne Yan-Yan Or, Hirokuni Takano, et al.
Molecular Cancer Therapeutics|November 8, 2006
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cellsPhilip L Lorenzi, William C Reinhold, Martina Rudelius, et al.
Nature Communications|October 23, 2020
Targeting N-myristoylation for therapy of B-cell lymphomasErwan Beauchamp, Megan C Yap, Aishwarya Iyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerRoshan Agarwal, Ana-Maria Gonzalez-Angulo, Simen Myhre, et al.
Pageof 159